Companies: 10,795·Total market cap: $144.5T

BeOne Medicines Ltd.

BeOne Medicines Ltd.

ONCNASDAQHealthcare● Active

$270.10

$-9.83(-3.51%)

Market Cap$28.9B

P/E Ratio—

52W High$385.22

52W Low$239.25

Avg Volume225K

Open$275.18

Beta0.49

股票排行：Medical - Pharmaceuticals·Healthcare·查看全部市值排行 →

BeOne Medicines Ltd.（ONC）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ONC · 截至 Jun 8, 2026

关键指标

EPS (TTM)$49.88Earnings history

PE Ratio (TTM)5.4×PE Ratio deep dive

Revenue (TTM)$5.7BFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding109.1MShares outstanding history

Next EarningsAug 5, 2026Est.Earnings history

探索 BeOne Medicines Ltd. 数据

分析师预测$399 · Buy

股息不分红

营收$5.3B+40.23%

盈利EPS $33.80+652.29%

财务快照

FY 2025Revenue$5.34B▲ +40.23% YoY

202320242025

FY 2025Net Income$286.9M▲ +144.50% YoY

202320242025

FY 2025EPS$33.80▲ +652.29% YoY

202320242025

TTM:Revenue: $5.74BNet Income: $513.0MEPS: $49.88View income statement →

分析师评级与目标价

Buy14 位分析师

Strong Buy

0

Buy

13

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$340.00Low

$270.10Current

$399.11Avg Target上涨空间 47.76%

$436.00High

合计: 14 · 买入占比: 92.9%

根据过去 3 个月内 14 位华尔街分析师，ONC 共识评级为 Buy，12 个月平均目标价 $399.11 （较现价 $270.10 上涨空间 47.76%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

BeOne Medicines Ltd.

$270.10-3.51%$28.9B #2

Agilent Technologies, Inc.

$135.44-2.12%$38.3B #3

$66.81+0.35%$32.6B #4

GE HealthCare Technologies Inc.

$64.67+1.35%$29.4B #5

$350.08+0.08%$42.0B #6

Insmed Incorporated

$94.22-10.20%$20.4B

股票表现

1D-3.51%

1W-1.38%

1M-13.46%

3M-10.30%

YTD-11.10%

1Y+2.40%

5Y-22.39%

关于 BeOne Medicines Ltd.

CEOJohn V. Oyler

IPO DateFeb 2, 2016

Employees11,000

CountryUS

Websitebeonemedicines.com

BeOne Medicines Ltd. BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies. Founded in 2010 and headquartered in Cambr…

Medical - Pharmaceuticals HealthcareNASDAQADRUS

关于股票概览与关键数据

BeOne Medicines Ltd.（ONC）是 Medical - Pharmaceuticals 行业的 Healthcare 类公司，于 Feb 2, 2016 在 NASDAQ 上市。截至最近交易日，ONC 股价为 $270.10，市值约为 $28.9B。过去12个月累计回报 +2.40%，年初至今回报 -11.10%。

根据 14 位华尔街分析师，BeOne Medicines Ltd. 股票共识评级为Buy，12个月平均目标价为 $399.11。2025 财年 BeOne Medicines Ltd. 营收 $5.3B，净利润 $286.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，BeOne Medicines Ltd.（ONC）股价为 $270.10，在 NASDAQ 上市，52周区间为 $239.25 – $385.22。

ONC 最新股价ONC quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议